Status:
WITHDRAWN
Heart Rate Variability-Guided Exercise Training in Type 2 Diabetes
Lead Sponsor:
University of Illinois at Chicago
Collaborating Sponsors:
American Diabetes Association
Conditions:
Type 2 Diabetes
Diabetes Mellitus, Type 2
Eligibility:
All Genders
40-70 years
Phase:
NA
Brief Summary
The primary aim of this randomized clinical trial is to determine the effectiveness of a 16 wk individualized aerobic exercise program, using heart rate variability to guide the exercise prescription,...
Detailed Description
This study will examine participant's fitness levels before and after a 16 week intervention period. There are two study visits prior to starting the intervention period. During Baseline Study Visit #...
Eligibility Criteria
Inclusion
- Body mass index range = 30.0 to 40.0 kg/m2
- Being sedentary (\<1 h regular physical activity/wk)
- Medication stable for 3 mo.
- Current use of physician confirmed diabetes medication, fasting glucose values ≥ 126 mg/dL and 2 hr oral glucose tolerance test (OGTT) values ≥ 200 mg/dL will be used as the criteria for type 2 diabetes
Exclusion
- Type 1 diabetes, \[insulin use\]
- Major depressive disorder
- Severe neuropathy
- Current tobacco use (must have quit for 1 yr or more if a previous user)
- Renal, liver, peripheral artery, or carotid artery disease
- Current cancer (must be at least 6 mo cancer-free)
- Beta-blockers
- Perimenopausal women, post-menopausal women experiencing hot flushes and not on hormone therapy
- Alcohol consumption greater than 7 drinks/wk
- Acute coronary syndrome within the last 6 mo, heart failure, pacemaker, and any additional contraindications to participation in exercise testing or an exercise training program.
Key Trial Info
Start Date :
June 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 3 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04910997
Start Date
June 1 2021
End Date
May 3 2022
Last Update
April 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Illinois at Chicago
Chicago, Illinois, United States, 60608